These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Development of an in-vitro model to study the growth characteristics of Staphylococcus epidermidis in continuous ambulatory peritoneal dialysis. Brant JA; Hanlon GW; Denyer SP J Pharm Pharmacol; 1998 Oct; 50(10):1195-203. PubMed ID: 9821670 [TBL] [Abstract][Full Text] [Related]
3. The effect of peritoneal dialysis solutions on rifampin action against Staphylococcus epidermidis in the fluid and biofilm phases of growth. Richards GK; Gagnon RF; Obst G; Kostiner GB Perit Dial Int; 1993; 13 Suppl 2():S341-4. PubMed ID: 8399605 [TBL] [Abstract][Full Text] [Related]
4. Impact of dialysis fluid on the susceptibility of Staphylococcus epidermidis biofilms to rifampin. Gagnon RF; Richards GK; Kostiner GB; Morcos R Adv Perit Dial; 1993; 9():183-6. PubMed ID: 8105919 [TBL] [Abstract][Full Text] [Related]
5. Bacterial aggregation in relation to peritoneal dialysis. Reid G; Schwarz-Faulkner S; McGroarty JA; Bruce AW Perit Dial Int; 1990; 10(1):21-4. PubMed ID: 2085576 [TBL] [Abstract][Full Text] [Related]
6. Recovery of S. epidermidis and E. coli from effluent peritoneal dialysate. Bailie GR; Eisele G; Venezia RA; Litynski J; Hughes H Perit Dial Int; 1991; 11(1):69-71. PubMed ID: 2049426 [TBL] [Abstract][Full Text] [Related]
7. Response of chronic renal failure mice to peritoneal Staphylococcus epidermidis challenge: impact of repeated peritoneal instillation of dialysis solution. Gallimore B; Gagnon RF; Richards GK Am J Kidney Dis; 1989 Sep; 14(3):184-95. PubMed ID: 2773921 [TBL] [Abstract][Full Text] [Related]